Clinical Trial Update: The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating ROCK inhibitors for corneal outcomes in patients with glaucoma and pseudophakic bullous keratopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Pseudophakic Bullous Keratopathy

Snippet

Sponsor: University Hospital Dubrava | Conditions: Pseudophakic Bullous Keratopathy, Glaucoma | Phase 2, Phase 3 | Status: COMPLETED